Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08:34 | Diaceutics beruft Lauren DeWitt zur neuen Chefjuristin und Group Company Secretary | 1 | Investing.com Deutsch | ||
DIACEUTICS Aktie jetzt für 0€ handeln | |||||
08:18 | Diaceutics appoints Lauren DeWitt as general counsel and secretary | 2 | Investing.com | ||
08:00 | Diaceutics PLC - Diaceutics Announces Key Leadership Appointment | - | RNS | ||
Mi | Diaceutics vergibt Optionen an Führungskräfte und Schlüsselpersonal | 1 | Investing.com Deutsch | ||
Mi | Diaceutics issues share options to directors and key staff | 1 | Investing.com | ||
Mi | Diaceutics PLC - Issue of Share Options / PDMR Shareholdings | - | RNS | ||
22.07. | Diaceutics stock rises on 'strong' first half and contract expansion | 1 | Alliance News | ||
22.07. | Diaceutics bestätigt Jahresprognose nach starkem Umsatzwachstum im H1 | 2 | Investing.com Deutsch | ||
22.07. | Diaceutics maintains FY targets with 22% revenue growth in H1 | 2 | Investing.com | ||
22.07. | Diaceutics PLC - 22% Revenue Growth H125 representing 3-yr CAGR 25% | - | RNS | ||
17.07. | Diaceutics PLC - Expansion of PMx Commercialization Partnership | 1 | RNS | ||
10.07. | Diaceutics stock price target lowered to 185p by RBC on FX headwinds | 2 | Investing.com | ||
30.06. | Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights | - | RNS | ||
18.06. | Diaceutics PLC - Results of AGM | 1 | RNS | ||
06.06. | Diaceutics PLC - PDMR Shareholding /Share Incentive Plan and TVR | - | RNS | ||
21.05. | Diaceutics PLC - Notice of AGM and Posting of Annual Report | - | RNS | ||
19.05. | IN BRIEF: Diaceutics chair sells 500,000 shares after results release | 1 | Alliance News | ||
15.05. | Diaceutics PLC - Transaction by Persons Closely Associated to PDMRs | - | RNS | ||
13.05. | Diaceutics narrows loss, grows revenue in 'another strong year' | 1 | Alliance News | ||
13.05. | Diaceutics-Aktien steigen dank robustem organischem Wachstum | - | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
DEXCOM | 77,24 | 0,00 % | Aktienmarkt: Kurs der Aktie von Dexcom im Plus (73,7738 €) | Im Plus liegt aktuell die Aktie von Dexcom . Das Wertpapier kostete zuletzt 86,80 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von Dexcom: Die Aktie weist zur Stunde ein Kursplus von 0,44... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,710 | +0,57 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
SENSEONICS | 0,467 | +0,62 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately... ► Artikel lesen | |
RESHAPE LIFESCIENCES | 2,415 | 0,00 % | ReShape Lifesciences Inc. - 8-K, Current Report | ||
INTELLIGENT BIO SOLUTIONS | 1,475 | -100,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience | Data confirms Company's ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent... ► Artikel lesen | |
PAVMED | 1,000 | -100,00 % | PAVmed Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
SIEMENS HEALTHINEERS | 48,550 | +1,46 % | Ohne Wolfram kein Hightech - dieser Flaschenhals bringt Rendite: Almonty, Siemens Healthineers, Intel | Wolfram gilt aufgrund seiner Härte und Hitzebeständigkeit als Rüstungsmetall. Doch es ist auch einer der unsichtbaren Motoren der Hightech-Industrie. Wir erklären anhand von Beispielen aus der Medizintechnik... ► Artikel lesen | |
GERRESHEIMER | 46,100 | -2,25 % | BASF, Gerresheimer, Hugo Boss, Kontron, Puma, Symrise - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
FRESENIUS | 42,380 | +1,15 % | Fresenius: Kaufen, kaufen, kaufen | Am 06. August wird der Gesundheitskonzern Fresenius die Zahlen für das vergangene zweite Quartal des laufenden Jahres 2025 vorlegen. Im Vorfeld haben einige Analysten den DAX-Titel erneut genauer unter... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 20,480 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 19,700 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
PROGYNY | 23,200 | 0,00 % | Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE... ► Artikel lesen | |
GENEDX | 85,11 | 0,00 % | Exploring GeneDx Holdings' Earnings Expectations | ||
FRESENIUS MEDICAL CARE | 45,580 | +1,85 % | Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil | DJ Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil
DOW JONES--Fitch Ratings hat die Langfrist-Ratings von Fresenius Medical Care (FMC) mit "BBB-" bestätigt. Der Rating-Ausblick... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 54,08 | 0,00 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen |